Literature DB >> 23775649

VII. Management of nodular lymphocyte-predominant Hodgkin lymphoma.

Dennis A Eichenauer1, Andreas Engert.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23775649     DOI: 10.1002/hon.2067

Source DB:  PubMed          Journal:  Hematol Oncol        ISSN: 0278-0232            Impact factor:   5.271


× No keyword cloud information.
  2 in total

1.  Ofatumumab in relapsed nodular lymphocyte-predominant Hodgkin lymphoma: results of a phase II study from the German Hodgkin study group.

Authors:  D A Eichenauer; H Goergen; A Plütschow; D Wongso; K Behringer; S Kreissl; I Thielen; T Halbsguth; P J Bröckelmann; M Fuchs; B Böll; B von Tresckow; P Borchmann; A Engert
Journal:  Leukemia       Date:  2015-11-20       Impact factor: 11.528

Review 2.  Nodular lymphocyte-predominant Hodgkin lymphoma: a unique disease deserving unique management.

Authors:  Dennis A Eichenauer; Andreas Engert
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.